Purpose: Although warfarin is an effective oral anticoagu-lation (OAC) drug to reduce the risk of thromboembolism in patients with non-valvular atrial fibrillation (NVAF), long term follow-up data are scarce to be certain whether the target INR level is maintained in warfarin-treated patients in Korea. The aim of this study was to evaluate how well INRs are maintained within the target range using a new index, INR stability ( = 100 × number of INRs within target range/ total number of INR measurements) which we made, and to find out any correlation between thromboembolic events and INR stability. Materials and Methods: This study was an observational analysis of retrospectively collected data of 129 patients with NVAF from April 2000 to Dec...
BackgroundTime in therapeutic range (TTR) of international normalized ratio (INR) of 2.0 to 3.0 is i...
BACKGROUND - RATIONALE FOR STUDY: Atrial fibrillation is associated with an increased risk of stroke...
Background: Warfarin sodium reduces stroke risk in patients with atrial fibrillation, but internatio...
Objective: To determine the proportion of patients with non-valvular atrial fibrillation (NVAF) trea...
Objective: To evaluate how well patients with non-valvar atrial fibrillation (NVAF) were maintained ...
The Author(s) 2015. This article is published with open access at Springerlink.com Background Mainta...
Onur Başer (MEF Author)Limited information exists regarding the relationship between international n...
Abstract Background Although efficacious in stroke pre-vention in non-valvular atrial fibrillation, ...
Onur Başer (MEF Author)Background Although efficacious in stroke prevention in non-valvular atrial f...
For patients on warfarin therapy, an international normalized ratio (INR) recall interval not exceed...
Patients with atrial fibrillation are associated with a 4-5-fold risk of having a stroke. The most e...
We explored associations between INR measures and clinical outcomes in patients with AF using warfar...
Aim To evaluate differences in the treatment quality between often used oral anticoagulants, warfari...
BACKGROUND: Anticoagulation control is often summarized using the percentage of time spent in a ther...
Warfarin is well studied in patients with non-valvular atrial fibrillation (AF). It has low complica...
BackgroundTime in therapeutic range (TTR) of international normalized ratio (INR) of 2.0 to 3.0 is i...
BACKGROUND - RATIONALE FOR STUDY: Atrial fibrillation is associated with an increased risk of stroke...
Background: Warfarin sodium reduces stroke risk in patients with atrial fibrillation, but internatio...
Objective: To determine the proportion of patients with non-valvular atrial fibrillation (NVAF) trea...
Objective: To evaluate how well patients with non-valvar atrial fibrillation (NVAF) were maintained ...
The Author(s) 2015. This article is published with open access at Springerlink.com Background Mainta...
Onur Başer (MEF Author)Limited information exists regarding the relationship between international n...
Abstract Background Although efficacious in stroke pre-vention in non-valvular atrial fibrillation, ...
Onur Başer (MEF Author)Background Although efficacious in stroke prevention in non-valvular atrial f...
For patients on warfarin therapy, an international normalized ratio (INR) recall interval not exceed...
Patients with atrial fibrillation are associated with a 4-5-fold risk of having a stroke. The most e...
We explored associations between INR measures and clinical outcomes in patients with AF using warfar...
Aim To evaluate differences in the treatment quality between often used oral anticoagulants, warfari...
BACKGROUND: Anticoagulation control is often summarized using the percentage of time spent in a ther...
Warfarin is well studied in patients with non-valvular atrial fibrillation (AF). It has low complica...
BackgroundTime in therapeutic range (TTR) of international normalized ratio (INR) of 2.0 to 3.0 is i...
BACKGROUND - RATIONALE FOR STUDY: Atrial fibrillation is associated with an increased risk of stroke...
Background: Warfarin sodium reduces stroke risk in patients with atrial fibrillation, but internatio...